000 01122 a2200265 4500
005 20250516152252.0
264 0 _c20140313
008 201403s 0 0 eng d
022 _a1873-7862
024 7 _a10.1016/j.euroneuro.2013.04.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoldberg, Terry E
245 0 0 _aComment on "Cognition in schizophrenia: Summary Nice Consultation Meeting 2012".
_h[electronic resource]
260 _bEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
_cAug 2013
300 _a788-9 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAnimals
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aCognition Disorders
_xprevention & control
650 0 4 _aHumans
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aGomar, Jesus J
773 0 _tEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
_gvol. 23
_gno. 8
_gp. 788-9
856 4 0 _uhttps://doi.org/10.1016/j.euroneuro.2013.04.009
_zAvailable from publisher's website
999 _c22779645
_d22779645